$CLVT

Clarivate PLC (CLVT) (Q3 2026) Earnings Call Highlights: Recurring Revenue Growth Hits

Clarivate PLC reported Q3 2026 revenue of $482M, with 0.4% organic growth. Year-to-date revenue declined 5% due to disposals. Q3 loss was $26M, with operating cash flow at $110M. Guidance updated: 2026 revenue $1.965B-$1.985B, adjusted EBITDA $865M-$885M, free cash flow $320M-$340M. ACV growth expected 1.75%-2.25%.

Original reporting
Published Nov 4, 2026, 11:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clarivate PLC (CLVT) (Q3 2026) Earnings Call Highlights: Recurring Revenue Growth Hits — source image
Decision brief

The 30-second read

$CLVTBearishHigh
01

Why it matters

Guidance downgrade and flat earnings suggest near‑term downside, but debt reduction and AI product rollout could provide upside catalysts later in the year.

02

Market read

The earnings release provides fresh guidance that may drive short‑term price movement for CLVT and influence sentiment in the broader data‑analytics sector.

03

What to watch

The $290 M debt repurchases at discount and upcoming AI product pipeline may mitigate short‑term weakness.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Clarivate PLC released its Q3 2026 earnings call, highlighting flat profit, modest organic revenue growth, and updated full‑year guidance after divesting the A&G books business.

Company-level read

Ticker impact

$CLVTBearishHigh confidence
Context

Q3 2026 earnings call disclosed flat profit, modest revenue growth and lowered full‑year guidance.

Expected impact

likely pressure as the market prices in weaker revenue and flat profit guidance

Evidence & confidence

The company lowered full‑year revenue guidance and reported a loss from continuing operations, which typically triggers a sell‑off.

Market effects

Signals pressure for the information services sector as recurring revenue growth slows.

U.S. market may see modest pullback in tech‑focused indices.

Limited to investors tracking mid‑cap data‑analytics firms.

Counterpoint

If the debt buybacks and AI‑led platform launches exceed expectations, the stock could rebound.

Key entities

  • Clarivate PLC

    U.S.-listed information services provider (ticker CLVT).

  • Michael Easton

    Chief Financial Officer of Clarivate, discussed debt buybacks and guidance.

  • Matti Shem Tov

    Chief Executive Officer of Clarivate, commented on AI platforms and ACV growth.

Related articles

$CLVTHighAI 8/10

Clarivate Launches Cash Offers for Up to $500 Million of Notes

Clarivate (CLVT) initiated cash tender offers for up to $500 million in outstanding notes, including $400 million for 3.875% 2028 notes and $100 million for 4.875% 2029 notes. The 2029 notes offer $928.75 per $1,000 principal. Offers expire November 10, 2026, with settlement expected November 13, 2026, according to the company.

$CLVTMedAI 8/10

What Clarivate (CLVT) Said on Its Q3 Earnings Call

Clarivate (CLVT) reported Q3 earnings, highlighting 1% growth in recurring organic revenue and positive ACV growth. The company cited a U.S. Patent and Trademark Office selection and plans for an AI-native IP platform, IPOne. Margins expanded by 300 basis points, and the company updated its 2026 outlook, excluding divested businesses. CLVT expects $1.965B-$1.985B in revenue and $865M-$885M in adjusted EBITDA.

$CLVTMed

Clarivate Plc Q3 2026 Earnings Call Summary

Clarivate reported Q3 2026 earnings, highlighting 1.8% organic ACV growth and 300 basis points of adjusted EBITDA margin expansion. The company completed the Life Sciences & Healthcare divestiture, focusing on higher-quality, recurring revenue. Management expects Q4 2026 organic revenue growth to exceed 2% and targets 10-15% free cash flow growth in 2027. One-time transaction costs of $30 million were incurred, and free cash flow guidance was adjusted to $320M-$340M.